Cognetivity Neurosciences is a medical technology company developing an AI platform for early detection of cognitive impairment, dementia and Alzheimer's
London, England
Joined September 2017
- Tweets734
- Following463
- Followers785
- Likes890
#CognICA Shown to Save Tens of Millions of Dollars in Healthcare Costs Annually and Improve Patient Outcomes in the UK National Health Service #NHS:
mailchi.mp/cognetivity.com/c…
@FrontPubHealth
Our Latest PeerReviewed Study Highlights Cost-Efficiency and Improved Clinical Outcomes From Using #CognICA, Showing Savings of Over £40 Million Per Year Compared With Traditional #CognitiveAssessment Tools in Primary and Secondary Care.
frontiersin.org/articles/10.…
#HealthEconomics
Cognetivity Neurosciences Ltd retweeted
Today marks #WorldAlzheimersDay. We’re proud of our partner @Cognetivity who are making major advancements in the #dementia detection space.
Learn more about our partnership: intersystems.com/uk/success-…
📣 Exciting Partnership Announcement on World Alzheimer's Day!
Cognetivity Neurosciences Partners with No Fear Counselling to Pioneer Brain Health Assessment Through Groundbreaking AI Technology finance.yahoo.com/news/cogne…
#WorldAlzheimersDay #Cognetivity #NoFearCounselling
Cognetivity Neurosciences Ltd retweeted
Thrilled to announce that we've won the prestigious #CogX2023 Award for Best AI Product in Health! A big shoutout to our incredible team at @Cognetivity. The future of #Alzheimers care is here and now. Let's connect and make an impact together! 🌟🧠🏆 #HealthTech #AI #Innovation
Cognetivity Neurosciences Ltd retweeted
Excited to share our latest Publication! We explored how the Integrated Cognitive Assessment (ICA) can improve primary care referrals to memory services. 🧠
*ICA had Sensitivity of 93% for dementia
*Reduced unnecessary GP referrals by ~72%
frontiersin.org/articles/10.…
@Cognetivity
New Disease Modifying Drug for Alzheimer’s Disease Approved by FDA, Crucial Role for Cognetivity - mailchi.mp/cognetivity.com/n…
Following the approval of Leqembi, a breakthrough drug to treat Alzheimer's, our AI technology is positioned to provide crucial real-world evidence for the drug's effectiveness. As a result, our technology is well-positioned to provide the necessary basis for reimbursement by CMS
This is a great opportunity to enhance the benefits of early intervention and personalized care, ultimately promoting brain health, well-being, and improved quality of life. #CognetivityNeurosciences #CognICA #Alzheimers #Lecanemab
cognetivity.com/cognetivity_…
Cognetivity Partners with Clairvo to Advance AI Powered Brain Health Management in Japan - mailchi.mp/cognetivity.com/c…
Cognetivity to Play Pivotal Role in Delivery of New Alzheimer's Drugs - mailchi.mp/cognetivity.com/c…
Cognetivity Announces Collaboration with Alzheimer's Society - mailchi.mp/cognetivity.com/c…
Eli Lilly releases positive results on latest drug for Alzheimer’s disease - mailchi.mp/cognetivity.com/e…
Eli Lilly releases positive results on latest drug for Alzheimer’s disease - mailchi.mp/cognetivity.com/e…
Cognetivity Neurosciences Announces Agreement With Japanese Life Insurance Company - mailchi.mp/cognetivity.com/c…
Cognetivity Neurosciences Appoints Renowned Life Sciences Leader - mailchi.mp/cognetivity.com/c…
Cognetivity Unveils Groundbreaking Research on Cognition and Sleep - Extends Collaboration with University of Oxford - mailchi.mp/cognetivity.com/c…
Cognetivity Enters Commercial Agreement with UK-Based Brain Health Supplements Provider - mailchi.mp/cognetivity.com/c…
Cognetivity Publishes Outstanding Results & Expands Deployment With Senior Care Network in Singapore - mailchi.mp/cognetivity.com/c…
